Ataxia telangiectasia (AT) is a rare autosomal recessive disease resulting in progressive degeneration of multiple systems in the body. Both A-T homozygote and heterozygote are at increased risk of developing malignancy. We report a family in which three generations were affected by this disorder. Our index case is a 12-year-old female child, born of second degree consanguineous marriage diagnosed to have ataxia telangiectasia at the age of four years, now presented with fever and neck swelling of one month duration. Family history suggestive of ataxia telangiectasia in maternal uncle and younger sibling was present. History of premature coronary artery disease and death in paternal grandfather was present. On evaluation, child was diagnosed to have Alk negative anaplastic large T cell lymphoma. Management included genetic counseling, examination of all the family members, identification of A-T homozygote and providing appropriate care, regular surveillance of the heterozygote for malignancy.
Introduction
Ataxia-telangiectasia is multisystem, complex disorder first described by Syllaba and Henner in 1926 . [1] The syndrome subsequently received the name of Louis Bar, who first described progressive cerebellar ataxia and cutaneous telangiectasia in a Belgian child. The incidence is about 1 in 100,000 live birth. Males and females are equally affected and there are no racial or regional preferences.
Case Report
The index case is a 12-year-old female child with history of delayed walking and convulsions from 4 years of age, now presenting with progressive neck swelling and fever of one month duration. History of recurrent respiratory tract infection requiring hospital admission is present.
Further history reveals that her youngest brother and maternal uncle had similar illness. Her maternal uncle had convulsions and was wheel chair bound at the age of 12 years. He died at 35 years of age because of respiratory tract infection. Paternal grandfather died of myocardial infarction at 45 years of age. There is a healthy second brother among the three siblings. Parents were healthy with no motor disability. There was no unexplained neonatal death, miscarriage or abortion in the family. They were born to second degree consanguineous parents and were full term, normal at birth.
Course of illness started with unsteady gait and easy fall at 4 years of age. Difficulty in walking progressively increased and presently the child is chair bound. These were associated with difficulty in swallowing and speech. AT is a rare disease with a prevalence estimated to be less than 1 in 100 000. [2] [3] [4] The frequency of A-T mutant allele heterozygosity was reported to be 1. A-T heterozygotes present an excess risk of death (they die 7-8 y earlier than the normal population), mostly from ischemic heart disease (A-T carriers die 11 y younger than noncarriers) or cancer (A-T carriers die 4 y younger than noncarriers). [5] [6] [7] It was estimated that up to 8% of all cases of breast cancer are AT carriers. They are also found to be hypersensitive to ionizing radiation and radiomimetic drugs, thus they may not tolerate certain antineoplastic regimens. Identification of such heterozygote in cancer patients before treatment can allow the use of more appropriate therapeutic regimens.
Ataxia: Ataxia has its onset in infancy, becoming apparent when the child begins to walk and is relentlessly progressive. From this early stage, ataxia is associated with abnormal head movements and is slowly and steadily progressive; however, the normal development Medical Institutions, which is the following: [8] Ataxia or significant motor incoordination with raised alpha fetoprotein (AFP) (>2x) +3 of the following four The mother of these two siblings is an obligate carrier and is known to have increased risk of breast cancer.
However, the benefit of frequent screening mammograms must be balanced against the risk of radiosensitivity.
The current opinion is to have the routine screening for breast cancer. The carrier status of the unaffected brother is estimated to be 50%, but definitive test to identify this would be very helpful in counseling. All the other family members were thoroughly examined and genetic counseling was provided to them. They were also educated regarding the nature of the disease and the need to have regular screening for malignancy.
Conclusion
Ataxia telangiectasia is mainly a clinical diagnosis and unnecessary, costly investigations should be avoided.
Management includes genetic counseling, examination of all the family members, identification of A-T homozygote and providing appropriate care, regular surveillance of the heterozygote for malignancy.
